Following fields are empty!

1
Search
2
Select
3
Submit
48554
Journals
Go to Previous Page
Page 1773 of 2428
Go to Next Page

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

Pharmacogenomics and Personalized Medicine

eISSN: 1178-7066
DOAJ Logo
Publisher: Taylor and Francis
Visit Publisher homepageVisit journal homepage
Molecular MedicinePharmacology
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacognosy Communications

ISSN: 2249-0159eISSN: 2249-0167
Publisher: Emanuscript Services
Visit Publisher homepageVisit journal homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacognosy Journal

ISSN: 0975-3575
Publisher: Emanuscript Services
Visit Publisher homepageVisit journal homepage
Drug DiscoveryPharmacology
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacognosy Magazine

ISSN: 0976-4062eISSN: 0976-4062
Publisher: Sage Publishing
Visit Publisher homepageVisit journal homepage
Chemistry(all)Drug DiscoveryPharmaceutical Science

Pharmacognosy Magazine (Phcog Mag.) is Published Quarterly, Pharmacognosy Magazine (Phcog Mag.) serves the need of different scientists and others involved in medicinal plant research and development. Each issue covers different topics in natural product drug discovery, and also publishes manuscripts that describe investigations, clinical reports, methods, techniques and applications of all forms of medicinal plant research and that are of broad readership interest to users in industry, academia, and government. Phcog Mag. is a must-read magazine for medicinal Plant researchers —and it's an Open Access Publication.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacognosy Research

ISSN: 0976-4836eISSN: 0974-8490
Publisher: Pharmacognosy Network Worldwide
Visit Publisher homepageVisit journal homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacognosy Reviews

ISSN: 0973-7847eISSN: 0976-2787
Publisher: Pharmacognosy Network Worldwide
Visit Publisher homepageVisit journal homepage
Plant ScienceComplementary and alternative medicineDrug DiscoveryPharmacology
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacokinetics and Pharmacodynamics

ISSN: 2587-7836
Publisher: Publishing House OKI
Visit journal homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacological Reports

ISSN: 1734-1140eISSN: 2299-5684
Publisher: Springer Nature
Visit Publisher homepageVisit journal homepage
Medicine(all)Pharmacology

Journal of Lie Theory is a journal for speedy publication of information in the following areas: Lie algebras, Lie groups, algebraic groups, and related types of topological groups such as locally compact and compact groups. Applications to representation theory, differential geometry, geometric control theory, theoretical physics, quantum groups are considered as well. The principal subject matter areas according to the Mathematics Subject Classification are 14Lxx, 17Bxx, 22Bxx, 22Cxx, 22Dxx, 22Exx, 53Cxx, 81Rxx.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in hybrid Springer, Nature Publishing, and Palgrave Macmillan journals.

Eligible articles types are: original research and review papers.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacological Research

ISSN: 1043-6618eISSN: 1096-1186
DOAJ Logo
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
Pharmacology

Pharmacological Research provides a rapid information exchange medium for specialists within the discipline of pharmacology. The journal publishes papers on basic and applied pharmacological research and is proud of its rapid publication of accepted papers.Invited and unsolicited review articles are also featured.Research Areas are:• Biochemical and molecular pharmacology• Cardiovascular pharmacology• Gastrointestinal pharmacology• Clinical pharmacology, if addressing novel mechanisms of action• Respiratory tract pharmacology• Urogenital tract pharmacology• Pharmacology of tissue repair• Neuropharmacology, psychopharmacology, and neuroendocrinology• Chemotherapy and cancer therapy• Immunopharmacology• Pharmacological applications of genomics• Pharmacology of aging• Nutraceuticals, if relevant to human diseaseNote that ethnopharmacological studies generally do not fall into the scope of this journal. Exceptions are made for papers addressing the mechanisms of actions or the clinical applications of worldwide-used natural substances. Clinical studies on commercially-available nutraceuticals are also taken into consideration.Immediate rejection criteria are:1. Ethnopharmacological papers, namely studies that deal with locally-consumed plants.2. In vitro antioxidant activity of plant extracts and pure compounds isolated from them.3. Papers that describe pharmacological activities of plants which are not easily found worldwide, eg, Chinese herbs.4. Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed.5. Papers describing the pharmacological activities of natural compounds are considered only if they identify novel mechanisms of action. In particular, Pharmacol Research does not publish papers that describe• Single dose studies with very few animals, no dose-response studies.• In-vitro assays with single dose or very high dose, measuring only one endpoint.• Repetition of a simple bioassay for yet another extract or plant.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacological Research - Modern Chinese Medicine

eISSN: 2667-1425
DOAJ Logo
Publisher: Elsevier
Visit Publisher homepageVisit journal homepageView author guidelinesView aims and scope
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacological Research - Reports

ISSN: 2950-2004
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage

Pharmacological Research Reports (PREREP) is a journal that publishes articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern pharmacological topics.

PREREP publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials). PREREP is a sound-science journal and therefore novelty and perceived impact will not be considered in the evaluation process. However, the journal will focus on quality studies that advance our knowledge and will take measures to guarantee the replicability of the published material.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacological Reviews

ISSN: 0031-6997eISSN: 1521-0081
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
Molecular MedicinePharmacology

This quarterly journal showcases important review articles on topics of high current interest. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacological research. Natural products

ISSN: 2950-1997
Publisher: Elsevier
Visit Publisher homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacology

ISSN: 0031-7012eISSN: 1423-0313
Publisher: Karger Publishers
Visit Publisher homepageVisit journal homepageView author guidelines
Medicine(all)Pharmacology

Pharmacology is an international journal committed to sharing the latest findings, news, and concepts pertaining to drug discovery, development, and therapy. Original scientific research presented in this journal stretches from basic to clinical studies, mirroring the scope which spans from bench-to-bedside research to modern reverse translational studies and precision medicine approaches. The journal primarily publishes research articles, reviews and commentaries to encourage knowledge transfer and discussion among the audience with an interest in experimental and clinical pharmacology, toxicology, pharmaceutical medicine, and biomedical sciences.

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacology & Pharmacy

ISSN: 2157-9423eISSN: 2157-9431
Publisher: Scientific Research Publishing
Visit Publisher homepageVisit journal homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacology & Therapeutics

ISSN: 0163-7258eISSN: 1879-016X
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
Pharmacology (medical)Pharmacology

Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology. Since articles are commissioned, instructions to authors are provided by the editor responsible for recruiting the work. Celebrating its 20th year of scientific excellence, Pharmacology & Therapeutics continues to be among the top 10 most cited journals in pharmacology.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacology Biochemistry and Behavior

ISSN: 0091-3057eISSN: 1873-5177
Publisher: Elsevier
Visit Publisher homepageVisit journal homepage
BiochemistryClinical BiochemistryBehavioral NeuroscienceBiological PsychiatryPharmacologyToxicology

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely behavioral studies and toxicology studies will not be published unless they have directly demonstrable relevance to the areas of pharmacology or biochemistry. Papers describing the behavioral effects of novel psychoactive drugs in models of psychiatric diseases must include a positive control.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

This agreement provides Open Access publishing in Elsevier, Cell Press, and Lancet titles.
Fully OA journals come under a prepayment agreement.

Research and Review articles are covered, as well a Case Reports, Data in Brief, Micro-articles, Original Software Publications, Protocols, Replication Studies, Short Communications, Short Surveys, Video Articles, Practice Guidelines.

Please upload a copy of your manuscript to the Manuscript Notification Form
Go to Journal

Pharmacology Research and Perspectives

eISSN: 2052-1707
DOAJ Logo
Publisher: Wiley
Visit Publisher homepageVisit journal homepage
NeurologyPharmacology, Toxicology and Pharmaceutics(all)

perspectives, pharmacology, replication studies, target validation

Read more
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacology and Clinical Pharmacy Research

ISSN: 2527-7332eISSN: 2614-0020
DOAJ Logo
Publisher: Faculty of Medicine
Visit Publisher homepageVisit journal homepageView author guidelinesView aims and scope
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Pharmacology, Toxicology and Biomedical Reports

eISSN: 2395-4736
Publisher: Emanuscript Services
Visit Publisher homepageVisit journal homepage
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no institutional agreement for this title.

  • Fully OA can be paid by the Crick OA team.
  • For hybrid journals, you will need to either share your accepted manuscript through Crick.Figshare and ePMC, or pay for OA through a different grant (not from core funds).
  • For subscription-only journals you will need to share you accepted manuscript through Crick.Figshare and ePMC.

Regardless of route, please contact the Crick OA team on open-access@crick.ac.uk or fill out the submission form.

Further details can be found at: https://intranet.crick.ac.uk/our-crick/library-information-services/pages/open-access-and-publishing.

Please note: the team cannot pay for any other publication or colour fees, except for open access charges.

Go to Journal

Select Your Institution

Search and select your institution from the result list.